Jost B, Vilotte J L, Duluc I, Rodeau J L, Freund J N
Institut National de la Santé et de la Recherche Médicale, Unité 381, Strasbourg, France.
Nat Biotechnol. 1999 Feb;17(2):160-4. doi: 10.1038/6158.
We have investigated, in mice, an in vivo method for producing low-lactose milk, based on the creation of transgenic animals carrying a hybrid gene in which the intestinal lactase-phlorizin hydrolase cDNA was placed under the control of the mammary-specific alpha-lactalbumin promoter. Transgenic females expressed lactase protein and activity during lactation at the apical side of mammary alveolar cells. Active lactase was also secreted into milk, anchored in the outer membrane of fat globules. Lactase synthesis in the mammary gland caused a significant decrease in milk lactose (50-85%) without obvious changes in fat and protein concentrations. Sucklings nourished with low-lactose milk developed normally. Hence, these data validate the use of transgenic animals expressing lactase in the mammary gland to produce low-lactose milk in vivo, and they demonstrate that the secretion of an intestinal digestive enzyme into milk can selectively modify its composition.
我们在小鼠中研究了一种生产低乳糖牛奶的体内方法,该方法基于创建携带杂交基因的转基因动物,其中肠道乳糖酶 - 根皮苷水解酶cDNA置于乳腺特异性α - 乳白蛋白启动子的控制之下。转基因雌性在哺乳期乳腺泡细胞顶端表达乳糖酶蛋白和活性。活性乳糖酶也分泌到牛奶中,锚定在脂肪球的外膜上。乳腺中乳糖酶的合成导致牛奶乳糖显著降低(50 - 85%),而脂肪和蛋白质浓度无明显变化。用低乳糖牛奶喂养的幼崽发育正常。因此,这些数据证实了利用在乳腺中表达乳糖酶的转基因动物在体内生产低乳糖牛奶的方法,并且表明将一种肠道消化酶分泌到牛奶中可以选择性地改变其成分。